Article Details
Retrieved on: 2024-02-12 00:55:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Imugene Limited (ASX: IMU) has reported multiple developments across the ongoing trials in the quarter ended 31 December 2024.
Article found on: kalkinemedia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here